4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-23-006012
EVP & Group Pres, Cardiology sold 63,339 shares at $53.60 ($3,394,856)
- EVP & Group Pres, Cardiology acquired 56,921 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 1 in the form | +56,921 | $13.08 | $744,527 | 277,198 | D |
| 2023-05-16 | Sale : show line 2 in the form | −63,339 | $53.60 | $3,394,856 | 213,859 | D |
| Open-market sales · 63,339 sh · avg $53.60 · $3,394,856 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −56,921 | 0 | D |
Loading xslF345X04/doc4.xml…